Suppr超能文献

大流行头两年国家免疫技术咨询小组指南中使用的新冠疫苗的效益和风险的直接定量比较。

Direct quantitative comparison of benefits and risks of COVID-19 vaccines used in National Immunization Technical Advisory Groups Guidance during the first two years of the pandemic.

作者信息

Doyon-Plourde Pamela, Farley Ruth, Krishnan Ramya, Tunis Matthew, Wallace Megan, Zafack Joseline

机构信息

Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada.

Centre for Immunization Programs, Public Health Agency of Canada, Ottawa, ON, Canada; School of Public Health, University of Alberta, Edmonton, AB, Canada.

出版信息

Vaccine. 2024 Dec 2;42(26):126406. doi: 10.1016/j.vaccine.2024.126406. Epub 2024 Oct 9.

Abstract

INTRODUCTION

The balance of benefits and harms of vaccines are assessed by regulatory agencies and National Immunization Technical Advisory Groups (NITAGs) to inform vaccine authorization or guidance. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach has been adopted by many NITAGs to develop recommendations. During the COVID-19 pandemic, several NITAGs additionally used direct quantitative comparisons (DQCs) between benefits and risk of vaccination with or without a GRADE framework to support timely decision-making relating to emerging safety signals. This study aimed to document the role of DQCs as novel tools in NITAGs' work by identifying situations where DQCs have been clearly leveraged in NITAG guidance, as well as identifying their strengths and limitations.

METHODS

The MEDLINE database and NITAGs' websites listed in the Global NITAG Network were searched for NITAG publications on COVID-19 vaccines. Publications were included if a DQC between benefits and risks of any COVID-19 vaccine was explicitly used for NITAG decision-making. Two reviewers independently assessed publication eligibility and extracted data. A narrative description of the role of DQCs in NITAG guidance, DQCs' methods and limitations was conducted.

RESULTS

Overall, 23 publications with 18 DQCs used by seven NITAGs were included. Situations prompting these publications included new safety signals (n = 7), additional information available on previously identified safety signals (n = 4) and changing contexts (n = 15) (e.g., vaccine supply, and epidemiology). DQC simplicity made them accessible, timely, and allowed for transparent communication. DQCs heavily relied on assumptions making them sensitive to changes in model parameters. DQCs limitations made them not easily transferable to other contexts and they quickly became obsolete in the evolving context of the COVID-19 pandemic.

CONCLUSIONS

The use of DQCs by NITAGs during the COVID-19 pandemic allowed for rapid evidence-based decision-making in an evolving environment while maintaining public trust. However, if their use becomes standard practice, efforts should be made to address their limitations.

摘要

引言

监管机构和国家免疫技术咨询小组(NITAGs)会评估疫苗的利弊平衡,以为疫苗授权或指导提供依据。许多NITAGs采用了推荐分级评估、制定与评价(GRADE)方法来制定建议。在新冠疫情期间,一些NITAGs还在有或没有GRADE框架的情况下,对疫苗接种的益处和风险进行直接定量比较(DQC),以支持与新出现的安全信号相关的及时决策。本研究旨在通过确定DQC在NITAG指南中得到明确应用的情况,以及识别其优势和局限性,来记录DQC作为NITAG工作中的新工具所发挥的作用。

方法

在MEDLINE数据库和全球NITAG网络列出的NITAG网站上搜索关于新冠疫苗的NITAG出版物。如果任何新冠疫苗的益处和风险之间的DQC被明确用于NITAG决策,则纳入该出版物。两名评审员独立评估出版物的资格并提取数据。对DQC在NITAG指南中的作用、DQC的方法和局限性进行了叙述性描述。

结果

总体而言,纳入了7个NITAGs使用的18个DQC的23篇出版物。促使这些出版物发表的情况包括新的安全信号(n = 7)、先前确定的安全信号的更多可用信息(n = 4)以及不断变化的背景(n = 15)(如疫苗供应和流行病学)。DQC的简单性使其易于理解、及时,并能进行透明的沟通。DQC严重依赖假设,使其对模型参数的变化敏感。DQC的局限性使其不易转移到其他背景中,并且在新冠疫情不断演变的背景下很快过时。

结论

在新冠疫情期间,NITAGs使用DQC能够在不断变化的环境中进行快速的循证决策,同时保持公众信任。然而,如果将其使用变为标准做法,则应努力解决其局限性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验